Public company snapshot, recent ticker-linked headlines, and a path into evidence-backed AI research.
Latest price
$0.82
-2.64%
Alpha Vantage · 11/6/2026
Adjusted daily closes · 252 observations · as of Nov 6, 2026
1 month
-23.7%
3 months
-38.4%
6 months
-33.1%
1 year
-51.7%
Year to date
-33.0%
52-week range
$0.78 – $1.71
Latest reported period: Jun 30, 2026
Market cap
$5.1M
P/E
-3
P/B
0.4
P/S
3.4
Revenue
$1.51M
Net income
-$1.71M
Diluted EPS
-0.35
Gross margin
100.00%
Net margin
-113.20%
Return on equity
-16.00%
Total debt
$0
Cash
$1.36M
Free cash flow
-$875.09K
Reported quarterly values, newest first
| Period | Revenue | Net income | Gross margin | Net margin | Free cash flow |
|---|---|---|---|---|---|
| Jun 30, 2026 | $1.49M | $473.3K | 100.00% | 31.70% | -$475.19K |
| Mar 31, 2026 | $17.3K | -$683.2K | 100.00% | -3949.10% | $143.99K |
| Dec 31, 2025 | $4.07K | -$964.94K | 100.00% | -23726.10% | -$568.6K |
| Sep 30, 2025 | $0 | -$537.82K | — | — | $24.71K |
| Jun 30, 2025 | $1.98M | $672.34K | 99.60% | 34.00% | -$867.53K |
| Mar 31, 2025 | $199.35K | -$961.75K | 95.90% | -482.40% | -$641.45K |
| Dec 31, 2024 | $0 | -$511.96K | — | — | -$716.6K |
| Sep 30, 2024 | $3.85K | -$528.95K | 100.00% | -13746.10% | -$472.25K |
Reported figures can reflect company reporting conventions, restatements, or sector-specific accounting. Verify against filings before relying on a valuation comparison.
CVS Health plans to split into two publicly traded companies in the first half of 2028, separating healthcare services from retail pharmacies. The CVS Health business will include Aetna, while CVS Pharmacy...
Original sourceI’m old enough to remember the day when CVS, the big drugstore company, opted to get even bigger by acquiring the health insurer Aetna. “Today marks the start of a new day in healthcare and a transformative...
Original sourceWynn Resorts' stock dropped 3.71% after its Q3 2026 results missed revenue and EPS expectations across all major resort operations. Despite recent short-term gains, the stock is down significantly over the past year, though it is currently considered 35% undervalued by a popular narrative. However, risks like higher labor costs and potential project delays could challenge this valuation.
Original sourceCVS' recent decision to divide its retail pharmacies from its insurance and pharmacy-benefit operations has raised hopes of consumer savings as Americans continue to reel from high costs of living.
Original sourceCVS plans to put about 9,000 retail pharmacies into a separate public company while keeping Aetna and Caremark together. Completion is targeted for the first half of 2028.Why This MattersThe restructuring...
Original sourceThe company announced the plan Wednesday, Nov. 4, saying the move is intended to give each business more focus and flexibility as it works to make healthcare more affordable and accessible.
Original sourceCVS Health on Tuesday announced plans to split its sprawling conglomerate into separate health insurance and pharmacy businesses, a move one industry expert welcomed as a potential way to drive down costs for...
Original sourceCVS Health said Wednesday it will break itself into two companies, dividing its retail pharmacy and insurance businesses.The announcement unwinds past acquisitions that created a $103 billion industry...
Original source